Inmune Bio, Inc. | Business Contracts

Lease Agreement dated September 13, 2021 (Filed With SEC on September 15, 2021)

Form of Placement Agency Agreement (Filed With SEC on July 15, 2021)

Form of Securities Purchase Agreement (Filed With SEC on July 15, 2021)

Form of Option Agreement for Employees of the Company (Filed With SEC on June 24, 2021)

First Amendment to License Agreement (Filed With SEC on June 15, 2021)

INmune Bio, Inc. 2021 Stock Incentive Plan (Filed With SEC on June 3, 2021)

Form of Option Agreement between the Company and Non-Employee Directors (Filed With SEC on June 24, 2021)

Warrant to Purchase Common Stock issued to Silicon Valley Bank (Filed With SEC on June 15, 2021)

Warrant to Purchase Common Stock issued to SVB Innovation Credit Fund VIII, L.P (Filed With SEC on June 15, 2021)

Loan and Security Agreement (Filed With SEC on June 15, 2021)

Option Cancellation Agreement between INmune Bio Inc. and Xencor, Inc (Filed With SEC on June 15, 2021)

At-The-Market Sales Agreement, dated March 10, 2021, between the Company and BTIG (Filed With SEC on March 11, 2021)

Amendment to Exclusive License Agreement (Filed With SEC on November 5, 2020)

At-The-Market Sales Agreement, dated April 16, 2020, between the Company and BTIG (Filed With SEC on April 17, 2020)

INmune Bio, Inc. 2019 Stock Incentive Plan (attached hereto) (Filed With SEC on March 11, 2020)

Award Agreement dated as of February 4, 2020 (Filed With SEC on February 10, 2020)

Common Stock Repurchase Agreement (Filed With SEC on January 27, 2020)

Amendment to Securities Purchase Agreement between INmune Bio, Inc. and David J. Moss (Filed With SEC on May 17, 2019)

Amendment to Securities Purchase Agreement between INmune Bio, Inc. and Raymond J. Tesi (Filed With SEC on May 17, 2019)

Award Letter dated as of February 22, 2019 from the Alzheimers Association to INmune Bio, Inc (Filed With SEC on February 28, 2019)

Inmune Bio, Inc. (30)